Hypolipidemic Effects of Kaempferide-7-O-(4 ''-O-acetylrhamnosyl)-3-o-rutinoside in Hyperlipidemic Rats Induced by A High-Fat Diet

Xue-Zhong Zhao,Xu-Wen Li,Yong-Ri Jin,Xiao-Feng Yu,Shao-Chun Qu,Da-Yuan Sui

DOI: https://doi.org/10.3892/mmr.2011.714

IF: 3.423

2012-01-01

Molecular Medicine Reports

Abstract:Kaem pferide-7-O-(4 ''-O-acetyl rham nosyl)-3-O-rutinoside (A-F-B) is a novel flavonoid which is extracted from the leaves of Actinidia kolomikta. The aim of this study was to investigate the hypolipidemic effects of A-F-B in hyperlipidemic rats induced by a high-fat diet. Male Wistar rats were randomly divided into six groups: normal diet group, high-fat diet group, lovastatin (2.5 mg/kg) group and A-F-B (12.5, 25 or 50 mg/kg) groups. To evaluate the lipid-lowering effects of A-F-B, total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), atherogenic index (AI) and coronary risk index (CRI) were investigated. The activities of phosphatidate phosphohydrolase (PAP) and hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase in hepatic tissue were evaluated. Treatment with A-F-B to hyperlipidemic rats resulted in a significant decline in TC, TG, LDL-C, AI and CRI, with an increase in HDL-C level. The results also showed that A-F-B significantly decreased the activities of PAP and HMG-CoA reductase in hepatic tissue. These findings suggest that A-F-B improves lipid profiles. The mechanisms of A-F-B were associated with regulating the activities of PAP and H MG-CoA reductase in hepatic tissue.